je.st
news
Tag: samsung announce
Samsung and International Talent Support Announce Samsung Galaxy Award for Emerging Young Designers
2015-08-03 08:37:53| Semiconductors - Topix.net
Samsung Electronics Co., Ltd. announced its second year partnership with International Talent Support , a global platform and competition for young emerging creative talent, as well as this year's Samsung Galaxy Award featuring the Galaxy S6 and S6 edge. Samsung and ITS are recognizing young talent and forces of fashion with creative vision, encouraging them to explore their creative ideas, and ultimately create a product or art piece that unites technology and fashion for a chance to receive the Samsung Galaxy Award.
Tags: support
international
young
award
Samsung Electronics and Universal Pictures announce global marketing...
2015-06-28 08:05:40| Semiconductors - Topix.net
Home >> Business >> It And Technology >> Samsung Electronics And Universal Pictures Announce Global Marketing Partnership With Amblin Entertainment's Jurassic World Samsung Electronics Co. announces its global marketing partnership with Jurassic World, the long-awaited next installment of Steve Spielberg's groundbreaking Jurassic Park series.
Tags: global
marketing
electronics
pictures
Samsung Electronics and Universal Pictures announce global marketing...
2015-06-28 07:35:14| Electronics - Topix.net
Home >> Business >> It And Technology >> Samsung Electronics And Universal Pictures Announce Global Marketing Partnership With Amblin Entertainment's Jurassic World Samsung Electronics Co. announces its global marketing partnership with Jurassic World, the long-awaited next installment of Steve Spielberg's groundbreaking Jurassic Park series.
Tags: global
marketing
electronics
pictures
Merck and Samsung Bioepis Announce Pivotal Phase 3 Studies for Investigational Biosimilars SB4, Enbrel (Etanercept), and SB2, Remicade (Infliximab), Met Primary Endpoints
2015-06-10 14:46:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. & SEOUL, South Korea Data Presented for the First Time at the EULAR Annual Meeting Phase 1 Data for SB2, SB4 and SB5, an Investigational Biosimilar of Humira (Adalimumab), also Presented KENILWORTH, N.J. & SEOUL, South Korea--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced that pivotal Phase 3 clinical studies of SB4, an investigational biosimilar of Enbrel (etanercept), and SB2, an investigational biosimilar of Remicade (infliximab), met their primary endpoints, demonstrating equivalence to the originator medicine in patients with moderate to severe rheumatoid arthritis (RA) despite methotrexate therapy. Language: English Contact: Merck Media:Pamela Eisele, 267-305-3558Robert Consalvo, 908-236-1127orMerck Investors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879orSamsung Bioepis Media:Jamyung Cha, (82) 32-455-6137orSamsung Bioepis Investors:Sungjoon Park, (82) 32-455-6120 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: met
primary
studies
phase
Samsung and TeleHealth Services Announce Completion of New Patient Care Solution to Cut Costs of Interactive Patient Engagement Solutions in Half
2015-03-31 12:31:15| Industrial Newsroom - All News for Today
New array of Samsung Smart LED hospital televisions and SmarTigr interactive patient engagement solutions provide healthcare facilities with cost-effective technology solutions to enhance patient satisfaction, operational efficiencies, and care management. RALEIGH, N.C. TeleHealth Services, the nation's leading...
Tags: services
care
half
costs